Sprout Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://addyi.com
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
- Conditions
- Sexual Dysfunctions, Psychological
- Interventions
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2016-06-27
- Lead Sponsor
- Sprout Pharmaceuticals, Inc
- Target Recruit Count
- 1584
- Registration Number
- NCT00360555
- Locations
- 🇺🇸
511.75.01019 Boehringer Ingelheim Investigational Site, Seattle, Washington, United States
🇺🇸511.75.01014 Boehringer Ingelheim Investigational Site, Encinitas, California, United States
🇺🇸511.75.01017 Boehringer Ingelheim Investigational Site, Berkeley, California, United States
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2016-06-27
- Lead Sponsor
- Sprout Pharmaceuticals, Inc
- Target Recruit Count
- 880
- Registration Number
- NCT00360529
- Locations
- 🇺🇸
511.71.01006 Boehringer Ingelheim Investigational Site, Plantation, Florida, United States
🇺🇸511.71.01003 Boehringer Ingelheim Investigational Site, Danville, Pennsylvania, United States
🇺🇸511.71.01031 Boehringer Ingelheim Investigational Site, Pittsburgh, Pennsylvania, United States
Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
- Conditions
- Sexual Dysfunctions, Psychological
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- Sprout Pharmaceuticals, Inc
- Target Recruit Count
- 749
- Registration Number
- NCT00277914
- Locations
- 🇺🇸
511.74.01042 Boehringer Ingelheim Investigational Site, Columbus, Ohio, United States
🇺🇸511.74.01041 Boehringer Ingelheim Investigational Site, Las Vegas, Nevada, United States
🇺🇸511.74.01013 Boehringer Ingelheim Investigational Site, San Diego, California, United States